… Early stage lung cancer is still mainly treated by hand, but most patients have … neoadjuvant
treatment for patients with surgically resectable locally progressive non-small cell lung cancer …

… Perioperative immunotherapy for non-small cell lung cancer (… Ⅲ clinical studies of neoadjuvant
and adjuvant therapies for … Numerous studies on perioperative NSCLC immunotherapy …

… adjuvant chemotherapy still have a high risk of recurrence and metastasis. With the success
of immunotherapy in advanced non-small cell lung cancer (… for neoadjuvant immunotherapy …

… the first-line treatment for non-small cell lung cancer (NSCLC). … of targeted therapy and
immunotherapy as neoadjuvant therapy. … of neoadjuvant compared to adjuvant immunotherapy to …

… neoadjuvant immunotherapy for non-small cell lung cancer … with early stage and locally
advanced stage of non-small cell … However, neoadjuvant or adjuvant chemotherapy leads to …

… [Abstract] Objective To investigate the effect of a neoadjuvant … and metastasis of non-small
cell lung cancer (NSCLC) in a … adjuvant chemotherapy versus surgery alone in early-stage …

… Non-small cell lung cancer (NSCLC) is the most common … treatment of locally-advanced
NSCLC, and in the neoadjuvant … of neoadjuvant pembrolizumab and chemotherapy+adjuvant …

… for resectable non-small cell lung cancer (NSCLC). Neoadjuvant and adjuvant therapy have
… Expert consensus on tumor mutational burden for immunotherapy in lung cancer. Zhongguo …

… 的早期非 小细胞肺癌(non-small cell lung cancer, NSCLC)被检出.… number of patients with
non-small cell lung cancer (NSCLC) … neoadjuvant immunotherapy and postoperative adjuvant …

… of prognosis in patients with advanced non-small cell lung cancer (NSCLC) through the
utilization of … of the recent advancements in neoadjuvant immunotherapy for resectable NSCLC, …